181 related articles for article (PubMed ID: 31786009)
1. Synthesis and biological activities of amino acids functionalized α-GalCer analogues.
Ma W; Bi J; Zhao C; Zhang Z; Liu T; Zhang G
Bioorg Med Chem; 2020 Jan; 28(1):115141. PubMed ID: 31786009
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and Th1-immunostimulatory activity of α-galactosylceramide analogues bearing a halogen-containing or selenium-containing acyl chain.
Hossain MI; Hanashima S; Nomura T; Lethu S; Tsuchikawa H; Murata M; Kusaka H; Kita S; Maenaka K
Bioorg Med Chem; 2016 Aug; 24(16):3687-95. PubMed ID: 27325450
[TBL] [Abstract][Full Text] [Related]
3. Amide analogues of CD1d agonists modulate iNKT-cell-mediated cytokine production.
Wojno J; Jukes JP; Ghadbane H; Shepherd D; Besra GS; Cerundolo V; Cox LR
ACS Chem Biol; 2012 May; 7(5):847-55. PubMed ID: 22324848
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists.
Guillaume J; Pauwels N; Aspeslagh S; Zajonc DM; Elewaut D; Van Calenbergh S
Bioorg Med Chem; 2015 Jul; 23(13):3175-82. PubMed ID: 26003341
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of acyl-chain- and galactose-6''-modified analogues of α-GalCer for NKT cell activation.
Hsieh MH; Hung JT; Liw YW; Lu YJ; Wong CH; Yu AL; Liang PH
Chembiochem; 2012 Jul; 13(11):1689-97. PubMed ID: 22730199
[TBL] [Abstract][Full Text] [Related]
6. Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
Hung JT; Huang JR; Yu AL
J Biomed Sci; 2017 Mar; 24(1):22. PubMed ID: 28335781
[TBL] [Abstract][Full Text] [Related]
7. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells.
Tashiro T; Sekine-Kondo E; Shigeura T; Nakagawa R; Inoue S; Omori-Miyake M; Chiba T; Hongo N; Fujii S; Shimizu K; Yoshiga Y; Sumida T; Mori K; Watarai H; Taniguchi M
Int Immunol; 2010 Apr; 22(4):319-28. PubMed ID: 20181652
[TBL] [Abstract][Full Text] [Related]
8. 4"-O-Alkylated α-Galactosylceramide Analogues as iNKT-Cell Antigens: Synthetic, Biological, and Structural Studies.
Janssens J; Bitra A; Wang J; Decruy T; Venken K; van der Eycken J; Elewaut D; Zajonc DM; van Calenbergh S
ChemMedChem; 2019 Jan; 14(1):147-168. PubMed ID: 30556652
[TBL] [Abstract][Full Text] [Related]
9. 3-fluoro- and 3,3-difluoro-3,4-dideoxy-KRN7000 analogues as new potent immunostimulator agents: total synthesis and biological evaluation in human invariant natural killer T cells and mice.
Hunault J; Diswall M; Frison JC; Blot V; Rocher J; Marionneau-Lambot S; Oullier T; Douillard JY; Guillarme S; Saluzzo C; Dujardin G; Jacquemin D; Graton J; Le Questel JY; Evain M; Lebreton J; Dubreuil D; Le Pendu J; Pipelier M
J Med Chem; 2012 Feb; 55(3):1227-41. PubMed ID: 22243602
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of C6''-modified α-C-GalCer analogues as mouse and human iNKT cell agonists.
Guillaume J; Seki T; Decruy T; Venken K; Elewaut D; Tsuji M; Van Calenbergh S
Org Biomol Chem; 2017 Mar; 15(10):2217-2225. PubMed ID: 28221388
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of an acyl-chain unsaturated analog of the Th2 biasing, immunostimulatory glycolipid, OCH.
Velmourougane G; Raju R; Bricard G; Im JS; Besra GS; Porcelli SA; Howell AR
Bioorg Med Chem Lett; 2009 Jul; 19(13):3386-8. PubMed ID: 19481452
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant alpha-GalCer.
Lee T; Cho M; Ko SY; Youn HJ; Baek DJ; Cho WJ; Kang CY; Kim S
J Med Chem; 2007 Feb; 50(3):585-9. PubMed ID: 17266209
[TBL] [Abstract][Full Text] [Related]
13. Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramide.
Hogan AE; O'Reilly V; Dunne MR; Dere RT; Zeng SG; O'Brien C; Amu S; Fallon PG; Exley MA; O'Farrelly C; Zhu X; Doherty DG
Clin Immunol; 2011 Aug; 140(2):196-207. PubMed ID: 21493160
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 6"-triazole-substituted α-GalCer analogues as potent iNKT cell stimulating ligands.
Pauwels N; Aspeslagh S; Elewaut D; Van Calenbergh S
Bioorg Med Chem; 2012 Dec; 20(24):7149-54. PubMed ID: 23122935
[TBL] [Abstract][Full Text] [Related]
15. Novel thioglycoside analogs of α-galactosylceramide stimulate cytotoxicity and preferential Th1 cytokine production by human invariant natural killer T cells.
Melo AM; Zhang L; Dockry ÉF; Petrasca A; Ghnewa YG; Breen EP; Morrissey ME; O'Reilly C; Bruen R; O'Meara A; Lysaght J; Zhu X; Doherty DG
Glycobiology; 2018 Jul; 28(7):512-521. PubMed ID: 29688330
[TBL] [Abstract][Full Text] [Related]
16. Avidity of CD1d-ligand-receptor ternary complex contributes to T-helper 1 (Th1) polarization and anticancer efficacy.
Wu TN; Lin KH; Chang YJ; Huang JR; Cheng JY; Yu AL; Wong CH
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17275-80. PubMed ID: 21987790
[TBL] [Abstract][Full Text] [Related]
17. New CD1d agonists: synthesis and biological activity of 6″-triazole-substituted α-galactosyl ceramides.
Jervis PJ; Graham LM; Foster EL; Cox LR; Porcelli SA; Besra GS
Bioorg Med Chem Lett; 2012 Jul; 22(13):4348-52. PubMed ID: 22652050
[TBL] [Abstract][Full Text] [Related]
18. 4,5-cis unsaturated α-GalCer analogues distinctly lead to CD1d-mediated Th1-biased NKT cell responses.
Cui Y; Li Z; Cheng Z; Xia C; Zhang Y
Chem Res Toxicol; 2015 Jun; 28(6):1209-15. PubMed ID: 25955524
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and functional activity of labeled CD1d glycolipid agonists.
Jervis PJ; Polzella P; Wojno J; Jukes JP; Ghadbane H; Garcia Diaz YR; Besra GS; Cerundolo V; Cox LR
Bioconjug Chem; 2013 Apr; 24(4):586-94. PubMed ID: 23458425
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro evaluation of alpha-GalCer epimers.
Trappeniers M; Goormans S; Van Beneden K; Decruy T; Linclau B; Al-Shamkhani A; Elliott T; Ottensmeier C; Werner JM; Elewaut D; Van Calenbergh S
ChemMedChem; 2008 Jul; 3(7):1061-70. PubMed ID: 18418814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]